Phreesia (PHR - Free Report) reported $83.85 million in revenue for the quarter ended April 2023, representing a year-over-year increase of 32.4%. EPS of -$0.70 for the same period compares to -$0.99 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $80.64 million, representing a surprise of +3.97%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being -$0.80.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average healthcare services Clients: 3309 versus 3297.05 estimated by four analysts on average.
- Patient payment volume: $1.02 billion versus $1.03 billion estimated by four analysts on average.
- Average revenue per healthcare services client: $18.78 million versus $18.69 million estimated by three analysts on average.
- Revenus- Subscription and related services: $37.89 million compared to the $37.72 million average estimate based on five analysts. The reported number represents a change of +30.2% year over year.
- Revenus- Network solutions: $21.71 million compared to the $20.01 million average estimate based on five analysts. The reported number represents a change of +46% year over year.
- Revenus- Payment processing fees: $24.25 million compared to the $23.84 million average estimate based on five analysts. The reported number represents a change of +25.1% year over year.
View all Key Company Metrics for Phreesia here>>>Shares of Phreesia have returned -6.1% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Where Will Stocks Go…
If Biden Wins? If Trump Wins?
The answers may surprise you.
Since 1950, even after negative midterm years, the market has never had a lower presidential election year. With voters energized and engaged, the market has been almost unrelentingly bullish no matter which party wins!
Now is the time to download Zacks' free Special Report with 5 stocks that offer extreme upside for both Democrats and Republicans…
1. Medical manufacturer has gained +11,000% in the last 15 years.
2. Rental company is absolutely crushing its sector.
3. Energy powerhouse plans to grow its already large dividend by 25%.
4. Aerospace and defense standout just landed a potentially $80 billion contract.
5. Giant Chipmaker is building huge plants in the U.S.
Hurry, Download Special Report FREE >>
Phreesia (PHR - Free Report) reported $83.85 million in revenue for the quarter ended April 2023, representing a year-over-year increase of 32.4%. EPS of -$0.70 for the same period compares to -$0.99 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $80.64 million, representing a surprise of +3.97%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being -$0.80.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average healthcare services Clients: 3309 versus 3297.05 estimated by four analysts on average.
- Patient payment volume: $1.02 billion versus $1.03 billion estimated by four analysts on average.
- Average revenue per healthcare services client: $18.78 million versus $18.69 million estimated by three analysts on average.
- Revenus- Subscription and related services: $37.89 million compared to the $37.72 million average estimate based on five analysts. The reported number represents a change of +30.2% year over year.
- Revenus- Network solutions: $21.71 million compared to the $20.01 million average estimate based on five analysts. The reported number represents a change of +46% year over year.
- Revenus- Payment processing fees: $24.25 million compared to the $23.84 million average estimate based on five analysts. The reported number represents a change of +25.1% year over year.
View all Key Company Metrics for Phreesia here>>>Shares of Phreesia have returned -6.1% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Where Will Stocks Go…
If Biden Wins? If Trump Wins?
The answers may surprise you.
Since 1950, even after negative midterm years, the market has never had a lower presidential election year. With voters energized and engaged, the market has been almost unrelentingly bullish no matter which party wins!
Now is the time to download Zacks' free Special Report with 5 stocks that offer extreme upside for both Democrats and Republicans…
1. Medical manufacturer has gained +11,000% in the last 15 years.
2. Rental company is absolutely crushing its sector.
3. Energy powerhouse plans to grow its already large dividend by 25%.
4. Aerospace and defense standout just landed a potentially $80 billion contract.
5. Giant Chipmaker is building huge plants in the U.S.
Hurry, Download Special Report FREE >>
Get the latest research report on PHR - FREE